Vicenzo Teneggi

D3 (Drug Discovery and Development), A*Star, Singapore
When
22nd-23rd Aug 2017
Where
Seoul, South Korea
Grand Hilton Seoul
The era of a “one-size-fits-all” approach to patient treatment & drug development is over. Instead the mantra of delivering the right drug to the right patient at the right time – the very essence of personalised medicine – is taking over. The reason is simple, rapid technological advances in sequencing technology, the increase in computer power and algorithms to manage big data, the advent of artificial intelligence plus wide-spread public investment to support these advances means that precision medicine is rapidly realizing its potential of delivering superior outcomes for patients around the world
This year’s congress draws on a truly international panel to examine the advances in technology and the latest applications that will deliver the medicines of tomorrow.
Join this meeting and be part of an environment bringing together a multi-disciplined community who share one aim – developing ground breaking and impactful treatments for patients.
×
Director of Bioinformatics Core Institute of Health Science, Chinese Academy of Sciences, China
Country Head Medical Division Takeda Pharmaceuticals, South Korea
Health Informatics Director – Advanced Analytics Centre AstraZeneca, UK
Secretary General Global Centers of Excellence in Clinical Trials (SCI-Consortium), South Korea
D3 (Drug Discovery and Development), A*Star, Singapore
Head of Biostatistics, South Africa and Asia Quintiles, China
Director Samsung Genome Institute, South Korea
Director – Computational Biology and Bioinformatics Pfizer Worldwide Research & Development, US
Senior Director – Nutrition & Scientific Nature’s Bounty, US
Chief Data Scientist, Zuellig Pharma, Singapore
Senior Research Fellow Evan Newell, Singapore Immunology Network, A*STAR, Singapore
Head of Immunogenomics Core, Deputy Director, Immunomonitoring Platform, Singapore Immunology Network, A*STAR, Singapore
Chief Innovations Officer, Pathway Genomics, US
Professor and Consultant Chairman of the Technology Assessment Group, Mayo Clinic Center for Individualized Medicine, US
Director of Strategic Planning and Communication, Dong-A University Hospital’s Global Center of Excellence in Clinical Trial, Korea
Director of Bioinformatics Core Institute of Health Science, Chinese Academy of Sciences, China
Country Head Medical Division Takeda Pharmaceuticals, South Korea
Health Informatics Director – Advanced Analytics Centre AstraZeneca, UK
Secretary General Global Centers of Excellence in Clinical Trials (SCI-Consortium), South Korea
D3 (Drug Discovery and Development), A*Star, Singapore
Head of Biostatistics, South Africa and Asia Quintiles, China
Director Samsung Genome Institute, South Korea
Director – Computational Biology and Bioinformatics Pfizer Worldwide Research & Development, US
Senior Director – Nutrition & Scientific Nature’s Bounty, US
Chief Data Scientist, Zuellig Pharma, Singapore
Senior Research Fellow Evan Newell, Singapore Immunology Network, A*STAR, Singapore
Head of Immunogenomics Core, Deputy Director, Immunomonitoring Platform, Singapore Immunology Network, A*STAR, Singapore
Chief Innovations Officer, Pathway Genomics, US
Professor and Consultant Chairman of the Technology Assessment Group, Mayo Clinic Center for Individualized Medicine, US
Director of Strategic Planning and Communication, Dong-A University Hospital’s Global Center of Excellence in Clinical Trial, Korea
The power of genomics and big data is now transforming drug discovery, while artificial intelligence and biomarker developments are providing promising avenues to deliver truly individualised therapies. It is this dynamic convergence of technological advances and their potential that will be the subject of the talks given at the Precision Medicine Congress: Asia.
Download the AgendaGet news about the latest precision medicine and big data research and applications direct to your inbox.
Grand Hilton Seoul
353 Yeonhui-ro
Seodaemun-gu
Seoul, South Korea 03650
The Grand Hilton Seoul is located 15 minutes from downtown Seoul. Enjoy easy access to the city center, Itaewon and Hongik University subway station with our complimentary shuttle service. Our modern Convention Center, which can hold up to 2,500 guests, is ideal for any event. Pick any of our stylish restaurants and indulge in the gourmet cuisine, perfect for any occasion.
3 for the price of 2 offer
Discount applied automatically when registering 3 places at once.
Not applicable for solution provider companies or compatible with any other offers or discount codes.
All conference sessions
Lunches and refreshments
Access to exhibition room
All networking forums
Conference workbook
e-documentation pack
Option 1 – Please phone +603 2117 5193 and we will take your details over the phone
Option 2 – Please complete the form below to pay online
Fee: $50
For foreign organisation delegate ticket fee
Fee for representatives of organisations offering services and/or business & technology solutions and also to business consultants.
Molecular Health develops and provides IT-driven products and services for use in precision medicine. Our focus area is treatment decision support in oncology and we actively extend our research and development activities into many other areas of precision healthcare, e.g. a pharmacovigilance research tool in a partnership with the FDA. Our mission is to develop innovative and high-quality IT medical devices that help physicians meet the ‘data interpretation challenge’ to find better, more effective and safer treatments, based on an in-depth understanding of an individual patient’s clinical and molecular data.
http://www.molecularhealth.com/
×
OncoDNA, The Cancer Theranostic Company, is the European leading oncology company providing solutions for cancer treatments, at the same time contributing to the knowledge applied to the fight against cancer. OncoDNA’s team is fully dedicated to help oncologists worldwide developing services to enable better treatment choices and treatment efficacy monitoring. The reports and the results are displayed in a dynamic way through the web platform OncoSHARE in order to allow an easy and fast reading.
×Bio Preventive Medicine Corporation (BPM) is a clinical-staged biotech company, focusing on developing novel biomarker-based diagnostics for chronic diseases and oncology. Our first product, DNlite TM, is a non-invasive urinary test for monitoring the progression of Diabetic Kidney Disease (DKD). BPM is a leading company in the renal biomarker area. We can help in the development of drugs not only in evaluating renal efficacy but also renal safety.
×Clearbridge BioMedics pioneered the development of one of the world’s first automated and label-free cell retrieval systems. Utilizing our patented inertial focusing microfluidics technology, the ClearCell® FX1 System ensures unbiased enrichment of viable rare Circulating Tumour Cells (CTCs) from a single blood draw.
http://www.clearbridgebiomedics.com/
×Our sponsorship packages offer a wide range of attendance options to suit your budget and business needs in order to maximize return on investment.
If there is any other way you would like to sponsor or increase branding for your company at the event, please get in touch and we will be able to offer you a bespoke service.
Select which delegates you would like to meet in a series of prearranged twenty-minute one-to-one meetings, held during breakout sessions from the main conference agenda. Our conference team will be available at the sessions to ensure all your meetings take place on time.
Host your own half or full day pre or post event workshop to a dedicated audience around a subject of your choice. Global Engage will assist with the marketing of your workshop to provide a guaranteed audience.
Market to our event database and / or increase brand awareness through taking a poster position or sponsoring one of the refreshment breaks, lunches, drinks receptions or poster sessions. This can be supplemented by branding options such as placing your logo on the attendee lanyards or conference bags.
Showcase your technologies and products throughout the conference in the dedicated exhibition areas where all refreshment breaks and lunches take place, as well as the networking drinks reception at the end of day one.
Options include:
For further details please contact
Samuel Sackey
+603 2117 5195
Call us on +603 2117 5196
For details on attendees, packages and new opportunities, please contact our sponsorship team who will quickly provide everything you need to assess the conference for yourself.
Biocompare is the leading resource for up-to-date product information, product reviews, and new technologies for life scientists.
×Biomedicines (ISSN 2227-9059) is an open access journal devoted to research of naturally driven biomedicines, pharmaceuticals, and biopharmaceutical products. The topics include natural bioactive molecules, biologics, biosimilar, vaccines, gene therapies, cell-based therapies, targeted specific antibodies, recombinant therapeutic proteins, nanobiotechnology driven products, targeted therapy, bio imaging, biosensors, biomarkers, nano-similars, and nano-biosimilars.
×IJBT provides an international forum and refereed authoritative source of information in the field of Biotechnology and Biotechnics, with emphasis on management and economics, as well as the political and social issues. It aims to disseminate knowledge, provide a learned reference in the field, and establish channels of communication between academic and research experts, policy makers and executives in industry, commerce and investment institutions.
×Founded in Shanghai in 2002, GBI has built a diverse portfolio of market intelligence solutions for pharmaceutical and device companies and other service providers. Focused on China and the Latin American markets, GBI’s value-added industry information, news, and data services power individuals and organizations’ decision-making and enable more effective communication. As a trusted source of information, GBI has established long-term relationships with both multinational players and local firms, and continues to drive forward the health care industry.
GBI has offices in Shanghai, Beijing, and Washington D.C.
×Global Information, Inc. is an information service company holding offices in 6 countries and have sales agency contracts with over 300 research companies around the world. We sell 30,000 market research reports published by these publishers and accept custom-made research.
×Hospitals-Management is essentially a B2B online business and media platform that has under it wraps the largest global database of Healthcare buyers and suppliers. Hospitals-Management.com covers in-depth trends that shape industry dynamics and metamorphose global economics.
×Functional informatics and personalised medicine in the new era of biomedical sciences and computational sciences are interactive disciplines that hold great promise for the advancement of cutting-edge research and development in biomedical informatics and pharmaceutical sciences. IJFIPM is dedicated to promoting the research, education and awareness of functional informatics and personalised medicine, and provides a common platform for the cross-fertilisation of ideas by bridging important and complementary disciplines into an interactive and attractive forum.
×In the realm of Pharmacy, where innovation is rapid, Pharmaceutical-Tech stands adept at conceptualizing unique ideas relevant to the B2B space. Pharmaceutical-Tech is essentially a B2B online business, technology media platform and global magazine that have under its wraps the largest global database of Pharmacy buyers and suppliers.
×A one stop shop providing information on the latest developments within the field of precision medicine.
×PharmaVOICE magazine provides readers with insightful and thought-provoking commentary about the challenges and trends impacting the life-sciences industry in a multiple-perspective format through articles covering a range of issues from molecule through market. PharmaVOICE’s more than 41,000 BPA-qualified subscribers are also kept abreast of the latest trends and information through additional media resources, including WebLinx Interactive WebSeminars, Podcasts, Videocasts, White Papers, E-Surveys and e-Alerts.
×Pharmaceutical Daily is a Europe-based news portal offering stories about, features, clinical studies, business endeavours of pharmaceutical companies, and other topics related to the pharmaceutical industry. With a goal to deliver clear, informative and interesting stories from the pharmaceutical industry, focused on business of pharmaceutical companies, Pharmaceutical Daily strives to ensure the newest information to its readers. Contact: [email protected]
×Personalised and precision medicine has the potential to revolutionise not only the treatment but also the prevention of diseases. The latest special topic issues of ‘Public Health Genomics’ Access for All: A Personalized Approach and Getting Personal: The Future of Medicine and Clinical Trials focus on the key challenges and solutions in personalised and precision medicine. Public Health Genomics is the leading international journal focusing on the timely translation of genome-based knowledge and technologies into public health, health policies, and healthcare as a whole.
×The RareBase Networking Portal links people and companies throughout the world with an interest in rare and paediatric diseases.
×SciDoc Publishers is a major source provider of e-journals in the field of Science, Technology and Medicine (STM). The nature of journals – Open Access and Peer-reviewed. We are aimed with a sole motive in making a mark in the field of Open Access, by propagating the knowledge to the scientific community. Our prime concern involves, the knowledge to reach millions of readers and give them access to scientific publications – online.
×SelectScience® is a leading independent online resource that meets the information needs of the global scientific community. Through impartial reviews, expert advice, webinars, applications and more, SelectScience® helps scientists make decisions about products and techniques.
×The Swiss Biotech Association (SBA) is the national industry association for biotechnology, including pharmaceuticals, diagnostics, agriculture, food, cosmetics, environmental biotechnology, and specialty chemicals. Members are companies active in modern biotechnology, such as R&D, Production, Marketing and Sales, Finance, Services and Consulting. SBA provides a networking platform for Life Science clusters, academic and federal institutions the like.
×Technology Networks is an internationally recognised, online publisher that provides access to the latest scientific news, products, research, videos and posters. Our global community is made up of over 300,000 researchers and scientific professionals from the life science, drug discovery and analytical arenas
×Get news about new precision medicine and biomarker developments research and applications direct to your inbox.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.